| Title |
Effects of modafinil on working memory processes in humans
|
|---|---|
| Published in |
Psychopharmacology, June 2004
|
| DOI | 10.1007/s00213-004-1926-3 |
| Pubmed ID | |
| Authors |
Ulrich Müller, Nikolai Steffenhagen, Ralf Regenthal, Peter Bublak |
| Abstract |
Modafinil is a well-tolerated psychostimulant drug with low addictive potential that is used to treat patients with narcolepsy or attention deficit disorders and to enhance vigilance in sleep-deprived military personal. So far, understanding of the cognitive enhancing effects of modafinil and the relevant neurobiological mechanisms are incomplete. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Germany | 2 | <1% |
| United Kingdom | 2 | <1% |
| Switzerland | 1 | <1% |
| France | 1 | <1% |
| Portugal | 1 | <1% |
| Netherlands | 1 | <1% |
| India | 1 | <1% |
| Unknown | 199 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 47 | 22% |
| Researcher | 29 | 14% |
| Student > Master | 29 | 14% |
| Student > Ph. D. Student | 22 | 10% |
| Other | 15 | 7% |
| Other | 37 | 18% |
| Unknown | 32 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 51 | 24% |
| Medicine and Dentistry | 37 | 18% |
| Neuroscience | 26 | 12% |
| Agricultural and Biological Sciences | 14 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 38 | 18% |
| Unknown | 39 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#1,470,659
of 25,483,400 outputs
Outputs from Psychopharmacology
#353
of 5,337 outputs
Outputs of similar age
#1,702
of 59,326 outputs
Outputs of similar age from Psychopharmacology
#2
of 22 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,337 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,326 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.